To modify the design of preclinical trials: a lesson from the failure of neuroprotection trials in stroke
Li, Y.-s.
Zhonghua Nei Ke Za Zhi 49(9): 733-734
2010
ISSN/ISBN: 0578-1426 PMID: 21092440 Document Number: 646657
Document emailed within 1 workday
Related Documents
Lietman, P.; Temple, R.; Harrington, M.; Peck, C. 1990: Methodological issues in AIDS clinical trials. Discussion. Design of clinical trials--approaches to clinical trials design Journal of Acquired Immune Deficiency Syndromes 3 Suppl. 2: S27Richman, D.; Itri, L.; Johnson, M.F.; Eigo, J. 1990: Methodological issues in AIDS clinical trials. Discussion. Design of clinical trials--active control (equivalence) trials Journal of Acquired Immune Deficiency Syndromes 3 Suppl. 2: S88
Hauser, R.A.; Zesiewicz, T.A. 2006: Clinical trials aimed at detecting neuroprotection in Parkinson's disease Neurology 66(10 Suppl 4): S58-S68
Van den Bergh, M.; Bertrand, E.; Govaerts, I.; Koenig, I.; Biramane, J.; Englert, Y. 1995: Preclinical trials for mastering intracytoplasmic injection of a sole spermatozoid for the treatment of male infertility Contraception Fertilite Sexualite 23(6): 393-398
Langman, M.J. 1978: Treatment trials and their design Clinics in Gastroenterology 7(3): 583-594
Overall, J.E. 1989: Design issues in clinical trials Progress in Clinical and Biological Research 317: 1291-1299
Clifford Rose, F. 1985: Aspects of stroke trials British Journal of Clinical Practice. Suppl 39: 34-39
Prasad, V.K. 2019: Improving the design of pivotal clinical trials Clinical Advances in Hematology and Oncology: H&o 17(3): 150-152
Antczak-Bouckoms, A.; Chalmers, T.C. 1988: The importance of design and analysis in clinical trials Journal of Oral Implantology 14(1): 36-42
Cheson, B.D.; Phillips, P.H.; Trimble, E. 1994: Clinical trials. Referral resource. Phase Ii Ovarian Cancer Trials Oncology 8(4): 73-74
Dhalla, S.; Poole, G. 2014: Effect of race/ethnicity on participation in HIV vaccine trials and comparison to other trials of biomedical prevention Human Vaccines and Immunotherapeutics 10(7): 1974-1984
Trimble, E.L.; Schoenfeldt, M. 2004: Clinical trials referral source. Current randomized phase IIi trials in gynecologic cancer Oncology 18(13): 1642; 1645-1646
Cheson, B.D.; Carter, C.L.; Sznol, M. 1993: Clinical trials referral resource. NCI-sponsored trials of interleukin-6 (IL-6) Oncology 7(6): 43-44
Saxman, S.B.; Smiley, J.K.; Cheson, B.D. 1999: Clinical trials referral resource. Current trials in melanoma Oncology 13(9): 1239-1242
Gehan, E.A. 1982: Design of controlled clinical trials: use of historical controls Cancer Treatment Reports 66(5): 1089-1093
Fleming, T.R.; Richardson, B.A. 2004: Some design issues in trials of microbicides for the prevention of HIV infection Journal of Infectious Diseases 190(4): 666-674
Lusher, J.M. 1984: Assessment of response to treatment and design of clinical trials Progress in Clinical and Biological Research 150: 167-179
Moher, D. 1998: CONSORT: an evolving tool to help improve the quality of reports of randomized controlled trials. Consolidated Standards of Reporting Trials JAMA 279(18): 1489-1491
Bellamy, N.; Carette, S.; Ford, P.M.; Kean, W.F.; le Riche, N.G.; Lussier, A.; Wells, G.A.; Campbell, J. 1992: Osteoarthritis antirheumatic drug trials. III. Setting the delta for clinical trials--results of a consensus development (Delphi) exercise Journal of Rheumatology 19(3): 451-457
Dellinger, E.P. 1991: Design and evaluation of clinical trials of antimicrobial agents in surgery Surgery Gynecology and Obstetrics 172 Suppl: 65-72